Pages that link to "Q35955325"

The following pages link to Aberrant plasma levels of circulating miR-16, miR-107, miR-130a and miR-146a are associated with lymph node metastasis and receptor status of breast cancer patients (Q35955325):

Displaying 41 items.

• Extracellular MicroRNA in liquid biopsy: applicability in cancer diagnosis and prevention (Q26742027) (← links)
• The Role of MicroRNAs as Predictors of Response to Tamoxifen Treatment in Breast Cancer Patients (Q26782449) (← links)
• MicroRNA-146a promotes gastric cancer cell apoptosis by targeting transforming growth factor β-activated kinase 1 (Q33828286) (← links)
• SLC7A5 act as a potential leukemic transformation target gene in myelodysplastic syndrome (Q35866423) (← links)
• Micro-RNA-130a-3p Regulates Gemcitabine Resistance via PPARG in Cholangiocarcinoma (Q36385805) (← links)
• Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients (Q36750596) (← links)
• The potential for liquid biopsies in the precision medical treatment of breast cancer (Q36849660) (← links)
• microRNA expression profiling on individual breast cancer patients identifies novel panel of circulating microRNA for early detection. (Q36902655) (← links)
• Circulating microRNA-based screening tool for breast cancer (Q36905676) (← links)
• Examining plasma microRNA markers for colorectal cancer at different stages. (Q36998271) (← links)
• Endothelial and circulating C19MC microRNAs are biomarkers of infantile hemangioma (Q37268517) (← links)
• miR146a-mediated targeting of FANCM during inflammation compromises genome integrity (Q37564625) (← links)
• Blood and lung microRNAs as biomarkers of pulmonary tumorigenesis in cigarette smoke-exposed mice. (Q37686233) (← links)
• Bone morphogenetic protein 4 regulates microRNA expression in breast cancer cell lines in diverse fashion (Q38810546) (← links)
• Cell-free microRNAs in blood and other body fluids, as cancer biomarkers. (Q38842894) (← links)
• Towards a new standardized method for circulating miRNAs profiling in clinical studies: Interest of the exogenous normalization to improve miRNA signature accuracy (Q41954466) (← links)
• Circulating microRNAs in patients with hormone receptor-positive, metastatic breast cancer treated with dovitinib. (Q42370321) (← links)
• miR-146a and miR-146b in the diagnosis and prognosis of papillary thyroid carcinoma (Q47629674) (← links)
• Role of micro-RNAs in breast cancer surgery. (Q47728281) (← links)
• A Semi-Supervised Learning Algorithm for Predicting Four Types MiRNA-Disease Associations by Mutual Information in a Heterogeneous Network (Q50421175) (← links)
• miR-10b, miR-26a, miR-146a And miR-153 Expression in Triple Negative Vs Non Triple Negative Breast Cancer: Potential Biomarkers (Q51182190) (← links)
• A pilot study on plasma levels of micro-RNAs involved in angiogenesis and vascular maturation in patients with breast cancer (Q51213425) (← links)
• Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial (Q57282848) (← links)
• Different signatures of miR-16, miR-30b and miR-93 in exosomes from breast cancer and DCIS patients (Q58699582) (← links)
• Branched rolling circle amplification method for measuring serum circulating microRNA levels for early breast cancer detection (Q58733916) (← links)
• Exosomal microRNAs as tumor markers in epithelial ovarian cancer (Q58776553) (← links)
• Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review) (Q58799160) (← links)
• Advancing Biomarker Development Through Convergent Engagement: Summary Report of the 2nd International Danube Symposium on Biomarker Development, Molecular Imaging and Applied Diagnostics; March 14–16, 2018; Vienna, Austria (Q63610247) (← links)
• Urinary Exosomal MicroRNAs as Potential Non-invasive Biomarkers in Breast Cancer Detection (Q89949998) (← links)
• Differential expression of circulating serum miR-1249-3p, miR-3195, and miR-3692-3p in non-small cell lung cancer (Q90677001) (← links)
• Circulating miRNAs as Diagnostic and Prognostic Biomarkers in Common Solid Tumors: Focus on Lung, Breast, Prostate Cancers, and Osteosarcoma (Q90721521) (← links)
• miR-103/107 prolong Wnt/β-catenin signaling and colorectal cancer stemness by targeting Axin2 (Q91622225) (← links)
• Effects of MiR-107 on The Chemo-drug Sensitivity of Breast Cancer Cells (Q92188887) (← links)
• Variance component analysis of circulating miR-122 in serum from healthy human volunteers (Q92203798) (← links)
• Circulating MicroRNAs in Cancer: Potential and Challenge (Q92405505) (← links)
• Why the Gold Standard Approach by Mammography Demands Extension by Multiomics? Application of Liquid Biopsy miRNA Profiles to Breast Cancer Disease Management (Q92755500) (← links)
• miR-107 Enhances the Sensitivity of Breast Cancer Cells to Paclitaxel (Q92799775) (← links)
• Identification of Cell-Free Circulating MicroRNAs for the Detection of Early Breast Cancer and Molecular Subtyping (Q93108232) (← links)
• Clinical Translatability of "Identified" Circulating miRNAs for Diagnosing Breast Cancer: Overview and Update (Q93109146) (← links)
• Plasma Level of MicroRNAs, MiR-107, MiR-194 and MiR-210 as Potential Biomarkers for Diagnosis Intestinal-Type Gastric Cancer in Human (Q95728493) (← links)
• Circulating miRNAs in HER2-Positive and Triple Negative Breast Cancers: Potential Biomarkers and Therapeutic Targets (Q99562732) (← links)